Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Lehman who wrote (1201)	3/19/1999 10:39:00 AM
From: Bob Schommer	Read Replies (1) \| Respond to of 1501

Thank you Harold for your balanced perspective. My concern is mainly over how quickly they would potentially be meted out as the prospect for Inflazyme over the next 6-9 months is significant with impending clinical trials. Naturally, existing shareholders don't want to suffer further dilution at these levels when around the corner there is a fairly good probability you get some respect for the paper. Regards, Bob

To: Harold Lehman who wrote (1201)	3/19/1999 5:05:00 PM
From: David Wolfson	Respond to of 1501

I understand very little about company protocols for issuing stock, but at a very fundamental level it doesn't seem like it could be a good thing for the company. I mean, isn't it like printing more money, where the more you print the less it's worth? Could someone could clarify in what way this could possibly be good for IZP? Also, if the company is AUTHORIZED to issue the shares, does that mean it WILL issue the shares? Or simply that it has the option to when it wants? I certainly can't complain about the way the stock moved today--I just wish I understood more about this.